GO:0040029 epigenetic regulation of gene expression: Chromatin Remodeling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0040029 (epigenetic regulation of gene expression) describes a biological process that modulates gene expression through chromatin remodeling, histone modification, or DNA methylation, and can be maintained across cell divisions.
• This process is essential for normal development and tissue-specific gene expression, and its disruption is linked to cancer, asthma, renal disease, and endometrial disorders [2,3,4,6,8].
• Key molecular players include DNA methyltransferases (DNMT1, DNMT3A, DNMT3B), histone acetyltransferases (EP300, CREBBP), histone deacetylases (HDAC1, HDAC2), histone methyltransferases (EZH2, SUV39H1), and chromatin remodelers (SMARCA4) [1,2].
• Environmental factors such as metals and endocrine signals can alter epigenetic marks, influencing gene expression programs [5,6].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of epigenetic regulators in disease and development [2,3].
• Understanding GO:0040029 is critical for identifying therapeutic targets in cancer and other diseases where epigenetic dysregulation drives pathology [2,3].
Description
Epigenetic regulation of gene expression (GO:0040029) is a fundamental biological process that controls when, where, and how genes are expressed without altering the underlying DNA sequence. It operates through chromatin remodeling, covalent modification of nucleosomal histones, and methylation of cytosine residues in DNA, and these marks can be stably propagated through cell divisions, providing a form of cellular memory. This process is essential for development, differentiation, and maintenance of tissue-specific gene expression programs. Dysregulation of epigenetic regulation is increasingly recognized as a hallmark of many human diseases, including cancer, asthma, and renal disorders [2,3,4,8]. Researchers study GO:0040029 to understand normal physiology and to develop epigenetic therapies that target chromatin-modifying enzymes [2,3]. The reversible nature of epigenetic marks makes them attractive drug targets, and several inhibitors of DNA methyltransferases and histone deacetylases are already in clinical use for hematological malignancies.
epigenetic regulation of gene expression At A Glance
| GO ID | GO:0040029 |
|---|---|
| GO term | epigenetic regulation of gene expression |
| Ontology | biological_process |
| Synonym | regulation of gene expression, epigenetic |
| Major function | Modulation of gene expression via chromatin remodeling, histone modification, and DNA methylation |
| Heritability | Can be maintained over many cell divisions and be heritable without the original signal |
| Key molecular players | DNMTs, HDACs, HATs, HMTs, chromatin remodelers |
| Disease relevance | Cancer, asthma, renal disease, endometrial disorders |
What Is GO:0040029?
GO:0040029, epigenetic regulation of gene expression, is defined as a process that modulates the frequency, rate, or extent of gene expression through chromatin remodeling, either by modifying higher-order chromatin fiber structure, nucleosomal histones, or cytosine methylation of DNA. Once established, this regulation may be maintained over many cell divisions and can even be heritable in the absence of the instigating signal.
Why Is epigenetic regulation of gene expression Important in Cell Biology?
Epigenetic regulation of gene expression is crucial because it provides a dynamic and reversible layer of control over the genome, enabling cells to respond to environmental cues and maintain distinct identities. Its disruption leads to widespread transcriptional changes that contribute to diseases such as cancer, where aberrant DNA methylation and histone modifications silence tumor suppressors or activate oncogenes [2,3]. In asthma, epigenetic changes link environmental exposures to persistent airway inflammation. In renal development, epigenetic regulation ensures proper nephron formation, and its perturbation can cause congenital anomalies. Thus, understanding GO:0040029 is essential for both basic biology and therapeutic development [2,3].
• Controls cell fate decisions and tissue-specific gene expression during development.
• Enables cellular memory and stable maintenance of expression states across divisions.
• Dysregulated in cancer, contributing to oncogene activation and tumor suppressor silencing [2,3].
• Mediates environmental effects on gene expression, as seen in asthma and metal exposure [4,5].
• Plays a key role in cyclical remodeling of the endometrium.
• Involved in plant development and stress responses through histone modifications.
• Provides targets for epigenetic drugs (e.g., DNMT inhibitors, HDAC inhibitors).
• Essential for renal development and function.
• Can be studied using CRISPR screens to identify epigenetic dependencies [2,3].
• Offers biomarkers for disease diagnosis and prognosis.
What Happens During epigenetic regulation of gene expression?
DNA Methylation
In simple terms: DNA methylation is like adding small tags to DNA that usually turn genes off.
DNA methylation involves the addition of a methyl group to cytosine residues, typically in CpG dinucleotides, catalyzed by DNA methyltransferases (DNMT1, DNMT3A, DNMT3B). This modification is generally associated with transcriptional repression and can be maintained through DNA replication by DNMT1, ensuring heritability of expression states. Aberrant DNA methylation patterns are common in cancer, where promoter hypermethylation silences tumor suppressor genes [2,3].
Histone Modifications
In simple terms: Histones are proteins that DNA wraps around; adding chemical marks to them can loosen or tighten DNA packaging.
Histone modifications include acetylation, methylation, phosphorylation, and ubiquitination, primarily on histone tails. Acetylation by histone acetyltransferases (HATs) such as EP300 and CREBBP generally promotes transcription, while deacetylation by histone deacetylases (HDACs) represses it [1,2]. Histone methylation can be activating or repressive depending on the residue and degree: H3K4me3 is active, while H3K27me3 and H3K9me3 are repressive. These marks are dynamically regulated by enzymes and are often altered in disease [2,3].
Chromatin Remodeling
In simple terms: Chromatin remodeling means moving or removing the protein spools to expose or hide genes.
ATP-dependent chromatin remodeling complexes, such as SWI/SNF (containing SMARCA4), slide, eject, or restructure nucleosomes to control DNA accessibility. This process is essential for transcriptional regulation and is frequently mutated in cancers [2,3]. Remodelers work in concert with histone modifiers to establish open or closed chromatin states.
Non-coding RNAs and Higher-Order Chromatin Structure
In simple terms: Non-coding RNAs can guide epigenetic machinery to specific DNA regions, and the 3D folding of DNA also influences gene activity.
Long non-coding RNAs (lncRNAs) such as XIST recruit chromatin-modifying complexes to target loci, as seen in X-chromosome inactivation. Higher-order chromatin organization, including topologically associating domains (TADs), also modulates gene expression by bringing enhancers into proximity with promoters. Disruption of these structures can lead to misregulation of gene expression in disease.
Key Genes Involved in GO:0040029 epigenetic regulation of gene expression
The following genes encode key epigenetic regulators that mediate DNA methylation, histone modification, and chromatin remodeling, and are frequently studied in the context of GO:0040029.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DNMT1 | Maintenance of DNA methylation patterns during replication | Target for cancer therapy; knockout models show global hypomethylation [1,2] |
| DNMT3A | De novo DNA methylation | Mutations in leukemia; knockout affects development [2,3] |
| DNMT3B | De novo DNA methylation | Mutations in ICF syndrome; involved in cancer [2,3] |
| HDAC1 | Histone deacetylation, transcriptional repression | Inhibitors used in cancer; knockout affects proliferation |
| HDAC2 | Histone deacetylation | Involved in asthma and cancer; target for therapy |
| EP300 | Histone acetyltransferase, transcriptional co-activator | Mutations in Rubinstein-Taybi syndrome and cancer |
| CREBBP | Histone acetyltransferase | Mutations in leukemia and Rubinstein-Taybi syndrome |
| EZH2 | Histone methyltransferase (H3K27me3) | Overexpressed in many cancers; inhibitor tazemetostat approved [2,3] |
| SUV39H1 | Histone methyltransferase (H3K9me3) | Role in heterochromatin formation and cancer |
| SMARCA4 | ATP-dependent chromatin remodeling | Frequently mutated in cancers; knockout models show dependency [2,3] |
| KDM6A | Histone demethylase (H3K27me3) | Mutations in cancer; involved in development |
| TET2 | DNA demethylation (5mC to 5hmC) | Mutations in leukemia and clonal hematopoiesis [2,3] |
| MBD3 | Component of NuRD complex, binds methylated DNA | Involved in transcriptional repression and development |
| CTCF | Insulator protein, organizes chromatin loops | Mutations affect gene regulation in cancer |
| ARID1A | Component of SWI/SNF complex | Frequently mutated in cancers; synthetic lethality with EZH2 inhibition [2,3] |
| KMT2A | Histone methyltransferase (H3K4me3) | Rearrangements in leukemia; target for therapy |
| BRD4 | Bromodomain reader of acetylated histones | Target for BET inhibitors in cancer |
How Is epigenetic regulation of gene expression Regulated?
Epigenetic regulation of gene expression is itself subject to regulation by various signaling pathways and environmental factors. For example, metal exposure can influence epigenetic marks, altering gene expression. In the endometrium, cyclical changes in hormone levels drive dynamic epigenetic modifications that regulate gene expression during the menstrual cycle. Additionally, metabolic intermediates such as acetyl-CoA and S-adenosylmethionine serve as substrates for histone acetyltransferases and DNA methyltransferases, linking cellular metabolism to epigenetic states. Dysregulation of these regulatory inputs can lead to disease [2,3].
epigenetic regulation of gene expression and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DNMT3A | Acute myeloid leukemia, clonal hematopoiesis | Knockout or point mutation in hematopoietic stem cells [2,3] |
| EZH2 | Lymphoma, breast cancer, prostate cancer | Overexpression or knockout in cancer cell lines [2,3] |
| HDAC2 | Asthma, steroid resistance | Knockout in airway epithelial cells |
| SMARCA4 | Lung adenocarcinoma, rhabdoid tumors | Knockout in cancer cell lines [2,3] |
| TET2 | Myeloid malignancies, clonal hematopoiesis | Knockout in hematopoietic cells [2,3] |
Cancer
Cancer is characterized by widespread epigenetic alterations, including global hypomethylation, promoter hypermethylation of tumor suppressor genes, and aberrant histone modifications [2,3]. Mutations in epigenetic regulators such as DNMT3A, TET2, EZH2, and SMARCA4 are common in hematological and solid tumors [2,3]. These changes contribute to oncogenesis and provide targets for epigenetic therapies, such as DNMT inhibitors (azacitidine, decitabine) and HDAC inhibitors (vorinostat, romidepsin).
Asthma
Asthma is a chronic inflammatory airway disease influenced by both genetic and epigenetic factors. Environmental exposures, such as allergens and pollutants, can induce epigenetic changes that alter gene expression in immune and airway cells, leading to persistent inflammation and remodeling. HDAC2 expression is reduced in severe asthma, correlating with steroid resistance.
Renal Development and Disease
Epigenetic regulation is critical for kidney development, and its disruption can lead to congenital anomalies of the kidney and urinary tract (CAKUT). For example, mutations in epigenetic regulators like EZH2 and KDM6A affect nephron progenitor differentiation. In renal cell carcinoma, epigenetic changes contribute to tumor progression.
Endometrial Disorders
The cyclical endometrium undergoes dynamic epigenetic changes that regulate gene expression in response to hormones. Dysregulation of these processes is implicated in endometriosis, infertility, and endometrial cancer. For instance, altered DNA methylation patterns have been observed in endometriotic tissue.
From epigenetic regulation of gene expression-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DNMT3A alter DNA methylation and gene expression? | DNMT3A knockout cell line (e.g., HEK293T) [1,2] |
| Does a specific EZH2 mutation affect histone methylation? | EZH2 point mutation knock-in (e.g., Y641F) [2,3] |
| Can we tag endogenous HDAC2 to study its localization? | HDAC2 knock-in with fluorescent tag |
| Does overexpression of BRD4 drive oncogenic transcription? | BRD4 overexpression in cancer cells |
| Which epigenetic regulators are essential for cancer cell growth? | CRISPR library screening (e.g., Brunello) [2,3] |
| Does TET2 deficiency affect 5hmC levels? | TET2 knockout in hematopoietic cells [2,3] |
How to Study the epigenetic regulation of gene expression Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ChIP-seq | Genome-wide binding of proteins and histone marks | Mapping H3K27me3, H3K4me3, and transcription factor binding [1,2] |
| Bisulfite sequencing | DNA methylation at single-base resolution | Analyzing promoter methylation and global methylation changes [1,3] |
| RNA-seq | Transcript abundance | Gene expression profiling after epigenetic perturbation [1,3] |
| ATAC-seq | Chromatin accessibility | Identifying open chromatin regions and remodeling events [1,3] |
| Hi-C | 3D chromatin interactions | Studying higher-order chromatin structure and TADs |
| CRISPR screens | Gene essentiality and epigenetic dependencies | Identifying epigenetic regulators required for cell growth [2,3] |
| Mass spectrometry | Histone modification quantification | Detecting changes in histone marks after drug treatment |
| Immunofluorescence | Localization of epigenetic proteins | Visualizing nuclear distribution of DNMTs, HDACs |
Chromatin Immunoprecipitation Sequencing (ChIP-seq)
ChIP-seq is used to map genome-wide binding of histone modifications and chromatin-associated proteins, providing insights into epigenetic regulation [1,2]. It can identify changes in H3K27me3, H3K4me3, and other marks after genetic perturbation.
Bisulfite Sequencing
Bisulfite sequencing detects DNA methylation at single-base resolution, enabling analysis of CpG methylation patterns across the genome [1,3]. It is commonly used to study promoter methylation and global hypomethylation in cancer.
RNA Sequencing (RNA-seq)
RNA-seq measures transcript levels and can reveal gene expression changes resulting from epigenetic perturbations [1,3]. It is often combined with ChIP-seq to correlate epigenetic marks with transcriptional output.
ATAC-seq
ATAC-seq assesses chromatin accessibility genome-wide, identifying open and closed regions that reflect epigenetic regulation [1,3]. It is useful for studying chromatin remodeling events.
How CRISPR Can Be Used to Study GO:0040029 epigenetic regulation of gene expression
Knockout
CRISPR knockout is used to delete epigenetic regulator genes (e.g., DNMT1, EZH2) to study their loss-of-function phenotypes, such as changes in DNA methylation, histone marks, and gene expression [2,3]. Knockout cell models are valuable for validating drug targets and understanding disease mechanisms.
Point Mutation
Point mutations can be introduced to mimic disease-associated mutations in epigenetic regulators, such as DNMT3A R882H or EZH2 Y641F, to study their effects on enzymatic activity and gene expression [2,3]. These models help dissect the functional consequences of specific mutations.
Knock-in
Knock-in of tags (e.g., GFP, HA) or reporter genes into endogenous loci allows visualization and purification of epigenetic proteins, enabling studies of their dynamics and interactions. Knock-in of mutant alleles can also be used to study gain-of-function effects.
Overexpression
Overexpression of epigenetic regulators (e.g., EZH2, BRD4) is used to model their oncogenic roles and to test targeted inhibitors [2,3]. Overexpression models can reveal dose-dependent effects on chromatin and transcription.
How EDITGENE Supports epigenetic regulation of gene expression Research
Researchers studying epigenetic regulation of gene expression-related genes often need to determine whether a candidate gene is causally involved in a specific disease or developmental process. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of epigenetic regulators.
Contact EDITGENE today to design your custom CRISPR model for epigenetic regulation of gene expression research.
Frequently Asked Questions About epigenetic regulation of gene expression
What is GO:0040029?
GO:0040029 is the Gene Ontology term for epigenetic regulation of gene expression, a biological process that modulates gene expression through chromatin remodeling, histone modification, or DNA methylation.
What genes are involved in epigenetic regulation of gene expression?
Key genes include DNMT1, DNMT3A, DNMT3B, HDAC1, HDAC2, EP300, CREBBP, EZH2, SUV39H1, SMARCA4, TET2, and others [1,2,3].
How does epigenetic regulation affect cancer?
Aberrant epigenetic marks can silence tumor suppressor genes or activate oncogenes, contributing to cancer initiation and progression [2,3].
What is the difference between genetic and epigenetic regulation?
Genetic regulation involves changes in DNA sequence, while epigenetic regulation modifies gene expression without altering the DNA sequence, often through reversible marks.
Can epigenetic changes be inherited?
Yes, some epigenetic marks can be maintained through cell divisions and even transmitted across generations, although the mechanisms vary.
What methods are used to study epigenetic regulation?
Common methods include ChIP-seq, bisulfite sequencing, RNA-seq, ATAC-seq, and CRISPR screens [1,2,3].
What diseases are linked to epigenetic dysregulation?
Cancer, asthma, renal diseases, endometrial disorders, and neurological disorders are among those linked to epigenetic dysregulation [2,3,4,6,8].
How can CRISPR be used to study epigenetic regulators?
CRISPR can create knockout, point mutation, knock-in, or overexpression models to dissect the function of epigenetic regulators [2,3].
What are histone modifications?
Histone modifications are chemical changes to histone proteins that influence chromatin structure and gene expression, such as acetylation and methylation.
What is DNA methylation?
DNA methylation is the addition of a methyl group to cytosine, typically repressing gene expression, and is catalyzed by DNMTs.
Conclusion
Epigenetic regulation of gene expression (GO:0040029) is a central mechanism controlling gene activity in development and disease. Its reversible nature makes it an attractive target for therapeutic intervention, and CRISPR-based models are invaluable for dissecting its components. EDITGENE provides end-to-end services to support researchers in this rapidly evolving field.
References
- 1. Zhang L et al.. 2020. Epigenetics in Health and Disease.. Adv Exp Med Biol 1253:3-55 PMID: 32445090
- 2. Dawson MA et al.. 2012. Cancer epigenetics: from mechanism to therapy.. Cell 150(1):12-27 PMID: 22770212
- 3. Ilango S et al.. 2020. Epigenetic alterations in cancer.. Front Biosci (Landmark Ed) 25(6):1058-1109 PMID: 32114424
- 4. Ntontsi P et al.. 2021. Genetics and Epigenetics in Asthma.. Int J Mol Sci 22(5) PMID: 33673725
- 5. Kimura T. 2017. [Metal-mediated Epigenetic Regulation of Gene Expression].. Yakugaku Zasshi 137(3):273-279 PMID: 28250320
- 6. Retis-Resendiz AM et al.. 2021. The role of epigenetic mechanisms in the regulation of gene expression in the cyclical endometrium.. Clin Epigenetics 13(1):116 PMID: 34034824
- 7. Le H et al.. 2025. Functions and Mechanisms of Histone Modifications in Plants.. Annu Rev Plant Biol 76(1):551-578 PMID: 39952674
- 8. El-Dahr SS et al.. 2019. Epigenetic regulation of renal development.. Semin Cell Dev Biol 91:111-118 PMID: 30172047
